Introduction
Adenosine deaminase (E.C.3.5.4.4) (ADA) is an enzyme involved in metabolism of purine through the salvage pathway, catalyzes the irreversible hydrolytic cleavage of adenosine to inosine and (deoxy) adenosine to (deoxy) inosine and production of ammonia in both nucleotides. 1 It is widely distributed in human tissues and shows highest activity in lymphoid tissues and it is necessary for the proliferation, maturation and function of lymphocytes, specifically for T lymphocytes. Its activity increases during antigenic and mitogenic responses of lymphocytes; therefore it is considered as an important immunoenzyme marker for assessing cell mediated immunity in diseases characterized by T lymphocyte proliferation and maturation. 2 Adenosine deaminase is a glycoprotein consisting of a single polypeptide chain of 311 amino acids. It was sequenced by Daddona et al. 3 The primary amino-acid sequence of ADA is highly conserved across species. 4 Studies on the crystal structure of mouse ADA showed that the protein is composed of eight stranded.
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The crystal structure has also revealed that ADA is a metallo -enzyme that complexes one mole of Zn +2 per mole of protein. 6,7 A high level of ADA in sera of cancer patients, in hepatitis, cirrhosis, and infectious mononucleosis has been reported. 8 Investigation of ascitic fluid of tuberculosis revealed a high activity of ADA enzyme.
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During the last decade, different disorders has been investigated and they revealed elevation in ADA activity in leprosy patients and in secondary liver tumors. 10 In a study conducted by Hasan G.H. etal 11 , who indicated that synovial fluid ADA activity increased in patients with rheumatoid arthritis and reactive arthritis, Sary et al, 12 study showed that serum total ADA and ADA-2 activity is closely associated with rheumatoid arthritis and these non-invasive investigations can be used as biochemical markers for inflammation status.
These provide additional information about the regarding disease activity along with the traditional indices such as ESR and Creactive protein (CRP). In a recent study, the highest value of ADA activity was observed in synovial fluid of patients with tubercular arthritis followed by rheumatoid, septic, osteo and post traumatic arthritis. 13 Finally deficiency of ADA activity was observed in severe combined immune deficiency disorders.
14 Acute leukemia is a malignancy of the hematopoitic progenitor cell. The malignant cell loses its ability to maturation and differentiation. These cells proliferate in an uncontrolled fashion and replace normal bone marrow elements. Most cases arise with no clear cause. However, radiation and some toxicant (benzene) are leukemogenic. In addition, a number of chemotherapeutic agents (especially procarbazine, melphalan, other alkylating agents, and etoposide) may cause leukemia. Most of the clinical findings in acute leukemia are due to replacement of normal bone marrow elements by the malignant cells. 15 Acute lymphoblastic leukemia (ALL) comprises 80% of the acute leukemias of childhood. It is also seen in adults causing approximately 20% of adult acute leukemias. Acute myelogenous leukemia (AML) is chiefly an adult disease with a median age at presentation of 60 years and an increasing incidence with advanced age. 16 This study aimed to investigate serum ADA activity in acute leukemia in order to evaluate it's role in the diagnosis of acute lymphoid leukemia.
A-SUBJECTS: This study was conducted over a period of six months, from January to July 2011. 30 patients with acute lymphoid leukemia (group 1), were included in the study (15 males & 15 females) with the mean ages (24.26±7.8), and (30) healthy volunteers, (15 males & 15 females), (group 2), mean ages (23.15±6.5), and. All the cases in both groups (1&2), were non smokers and non alcohol drinkers. B-SERUM SAMPLING: Four to six mls of venous blood was withdrawn from each individual using disposable syringes .The samples were immediately centrifuged for [10] min at 3000 rpm, and the serum was obtained and analyzed directly. C-METHOD Estimation of Serum ADA activity:-Serum ADA activity was determined for the two groups according to the method which was described by (Giusti, and Galanti, 1968) . 17 Principle of the Methodolgy:-Adenosine deaminase is easily assayed by measuring the amount of ammonia formed during its incubation for 60 minutes at (37C o ). Ammonia reacts with sodium hypochlorite at (pH6.5), in the presence of phenolnitroprusside as a catalyst, producing blue indophenols. The ammonia concentration is directly proportional to the intensity (measured at 630nm) of the color of indophenols produced. Reagents: 
Method

Method:
Calculation: Adenosine deaminase activity was calculated using the following equation: Activity of ADA in IU/L= (Atest-Acontrol/ Astandard-Ablank) ×50* (50*): is the concentration of working standard solution of ammonium sulphate. D-Effect of Na + & K + ions on ADA activity: The same protocols of the enzyme activity determination as shown in section (C) were implemented by the addition of (0.1 ml, of 0.5mM), of each of the ions (Na + and K + ), from the salts NaCl &KCl respectively. 
Results
Reagents
Test Control Standard Blank Phosphate buffer solution (pH6.5).
- Tables (2 and 3) , shows the effect of (0.1ml of 0.5mM, Na + and K + ) ions, as ions effect on S.ADA activity, the results showed that both ions increased the activity of S.ADA at different percentages in both groups. Table 2 : The effect of (0.5mM) Na + ions on S.ADA activity: 21 However, it was in disagreement with WG Yasmineh 22 , who indicated that adenosine deaminase is highly important for lymphocyte proliferation in children with ADA deficiency. Adenosine deaminase is an enzyme present in most mammalian tissues with highest acitivty in organs containing many lymphoid cells. Current interest in this enzyme has been stimulated by the finding that patients with inherited deficiency of ADA have a combined immunodeficiency. 23 Two ions (Na + and K + ) were used in this study, the results showed that they increased the activity of ADA, this by (AL-Taii. 2006) 24 .
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1.Binding to enzyme active site of 5'NT.
2.Facilitate the binding of substrate to enzyme 3.Altering the equilibrium constant of the enzymatic reaction. 4.Be a part of enzyme components and thus bind to side groups (Hasan, and Rwandozy, 2002).
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Studying the effects of metal ions could provide a normal approach to studying Cation-Cation interactions. In addition, it may permit the inclusion of substrate imbricate between the Cations supramolecular structure. Furthermore, it may display successive binding of different substrate yielding "cascade" type complexes. 26 Recently, both in vivo and in vitro specific proteins was found to bind metal ions, as it has been suggested that metal ions could influence the structural stability and, potentially the transition to the infectious scrapic form. 27 means that they can act as an activators. These results are similar to those reported by (AL-Taii. 2006). 24 Those ions may act as a cofactor for enzyme catalysing. These metal ions exert their action throughout:
Discussion
From the results of this study, one can conclude: 1-The mean serum activity of ADA, in acute lymphoid leukemia significantly is lower than that of healthy individuals .Hence, the measurement of serum activity of ADA may be used as biomarkers in the diagnosis of acute lymphoid leukemia. 2-ADA activity is related to the immunity status, more studies are required to confirm this theory. 
